divestment

glenmark nirma api deal valuation, glenmark life sciences nirma acquisition, glenmark debt problem solved by api sale, nirma expands pharma portfolio with glenmark api, glenmark api deal impact on shareholders, glenmark api deal open offer details, glenmark api deal future strategy
Latest News Deals Pharma

Glenmark sells API business to Nirma for $681M, wipes out debt

Anika Sharma

Glenmark Pharmaceuticals has successfully resolved its long-standing debt issue by divesting 75% of its active pharmaceutical ingredient (API) business. The ...

Pharmtales - your go-to source for comprehensive coverage of the pharmaceutical industry.

pharmtales
Latest Pharma News & Insights

© 2024 pharmtales.com | All rights reserved.

PRIVACY POLICY terms of service Contact us